We aimed to evaluate the antimicrobial effects of
Glycyrrhiza uralensis extract on
Streptococcus mutans and
Candida albicans and its biocompatibility for dental applications. The antimicrobial activity of the
G. uralensis extracts at concentrations of 50, 100, 150, and 200 µg/mL was assessed using agar disk diffusion tests, counting the total number of colony-forming units (CFUs), spectrophotometric growth inhibitory assays, and microbial morphology observations using scanning electron microscopy (SEM; Merin, Carl Zeiss, Oberkochen, Germany). We measured the polyphenol and flavonoid contents of
G. uralensis extracts using ultraviolet–visible spectrometry and the cytotoxicity of these extracts using an MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. We identified that
G. uralensis extracts had significant antimicrobial effects against
S. mutans and
C. albicans. The optical density of the experimental groups significantly decreased compared with that of the control group. SEM images revealed that the
G. uralensis extract affected the morphology and density of
S. mutans and
C. albicans. The extract concentration of flavonoids, but not polyphenols, increased with increasing concentrations of the
G. uralensis extract. Furthermore, cell viabilities were more than 70% for
G. uralensis extracts with concentrations of 50 and 100 μg/mL. Naturally derived
G. uralensis is biocompatible and exhibits an excellent antimicrobial effect against oral pathogens such as
S. mutans and
C. albicans. Thus,
G. uralensis extracts can be used for the development of oral products that treat and prevent oral diseases.
View Full-Text
This is an open access article distributed under the
Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited